drugset / Trial / NCT00150982
Alefacept Mechanism of Action in Psoriasis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine the mechanism of action of alefacept in patients with psoriasis.
Timeline
- Start
- 2003-09
- Primary completion
- —
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alefacept | Protein / enzyme biologic | 7.5 mg | Intravenous |